Patient-centered trial design in phase III advanced cancer trials: Control arm and endpoint selection, 2015–2024.
715 Background: Control arm selection affects patient experience and evidence supporting oncology practice. Contemporary patterns in comparator and endpoint selection across advanced cancer trials remain incompletely described. We evaluated Phase III advanced/metastatic cancer trials registered from 2015–2024....